(S)-Methyl morpholine-3-carboxylate, 95.0%, 250mg

Montelukast Sodium>98.0%(HPLC)(T)1g

(S)-TERT-BUTYL 3-(PYRIMIDIN-4-YLOXY)PYRROLIDINE-1-CARBOXYLATE, 95.0%, 1g

(R)-(1-Methylpiperidin-2-yl)methanol, 95.0%, 1g

(R)-PYRROLIDINE-3-CARBONITRILE HCL, 95.0%, 1g

Oxalic acid diethyl ester, >=99%, for synthesis, 2.5 l, plastic packaging.

Ethyl 2-chloro-4-iodobenzoate, 98.0%, 250mg

N,N-Bis[(1S)-1-phenylethyl]dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine, ?97.0%, 100mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-(tetrahydro-2H-pyran-4-yl)acetic acid, 95%, 250mg

7-Chloroquinazolin-4-ol, 95.0%, 100g

4-(Hydroxymethyl)phenoxymethyl Polystyrene Resin cross-linked with 1% DVB (200-400mesh) (0.5-1.0mmol/g)5g

(4-(N-(tert-Butyl)sulfamoyl)phenyl)boronic acid, 95.0%, 1g

Dapoxetine hydrochloride, 95.0%, 250mg